Antibiotic usage by surveillance category in Laos

Laos: Antibiotic usage by surveillance category was 15.33 defined daily doses per 1000 inhabitants per day in 2023. ▼ Falling

Latest (2023)
15.33 defined daily doses per 1000 inhabitants per day
Change on year
down 18.9%
World rank
12th
of 46 countries
All-time high
18.89 defined daily doses per 1000 inhabitants per day
in 2022
All-time low
15.33 defined daily doses per 1000 inhabitants per day
in 2023
Years of data
5
2019–2023

Antibiotic usage by surveillance category in Laos, 2019–2023

051015202019202120232019: 18.3 defined daily doses per 1000 inhabitants per day2020: 16.6 defined daily doses per 1000 inhabitants per day2021: 15.9 defined daily doses per 1000 inhabitants per day2022: 18.9 defined daily doses per 1000 inhabitants per day2023: 15.3 defined daily doses per 1000 inhabitants per day

Source: WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) (2025) – processed by Our World in Data. Measured in defined daily doses per 1000 inhabitants per day.

Analysis

Laos recorded 15.33 defined daily doses per 1000 inhabitants per day for antibiotic usage by surveillance category in 2023. That is the lowest value across all 5 years on record.

The figure is down 18.9% on the previous year and down 16.5% over five years.

That places Laos 12th out of 46 countries with data for 2023, putting it in the top quarter.

Averages by decade

DecadeAverage LowestHighest Years
2010s 18.35 defined daily doses per 1000 inhabitants per day 18.35 defined daily doses per 1000 inhabitants per day 18.35 defined daily doses per 1000 inhabitants per day 1
2020s 16.67 defined daily doses per 1000 inhabitants per day 15.33 defined daily doses per 1000 inhabitants per day 18.89 defined daily doses per 1000 inhabitants per day 4

Countries ranked near Laos

  1. 9 Spain 15.75 defined daily doses per 1000 inhabitants per day compare
  2. 10 Burkina Faso 15.61 defined daily doses per 1000 inhabitants per day compare
  3. 11 Iceland 15.59 defined daily doses per 1000 inhabitants per day compare
  4. 13 Benin 15.33 defined daily doses per 1000 inhabitants per day compare
  5. 14 South Africa 15.13 defined daily doses per 1000 inhabitants per day compare
  6. 15 Romania 14.79 defined daily doses per 1000 inhabitants per day compare

See the full ranking of 46 places →

More reference data data for Laos

All data for Laos →

Frequently asked questions

What is antibiotic usage by surveillance category in Laos?
Antibiotic usage by surveillance category in Laos was 15.33 defined daily doses per 1000 inhabitants per day in 2023, according to WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) (2025) – processed by Our World in Data.
What is the highest antibiotic usage by surveillance category recorded in Laos?
The highest recorded value was 18.89 defined daily doses per 1000 inhabitants per day in 2022.
What is the lowest antibiotic usage by surveillance category recorded in Laos?
The lowest recorded value was 15.33 defined daily doses per 1000 inhabitants per day in 2023.
How does Laos rank for antibiotic usage by surveillance category?
Laos ranks 12th out of 46 countries with data for 2023.
Where does this Laos data come from?
The figures come from WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) (2025) – processed by Our World in Data, published as part of Antibiotic usage by surveillance category. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
Antibiotic usage by surveillance category
Unit
defined daily doses per 1000 inhabitants per day
Source
WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) (2025) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
46 places, 344 data points, 2016–2023
Last refreshed

Total defined daily doses of AWaRe category: Access used per 1000 inhabitants per day. Access antibiotics have activity against a wide range of common pathogens and show lower resistance potential than antibiotics in the other groups.